Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma

• Main Authors: Stefanie Porkert (Author), Pamela Mai (Author), Constanze Jonak (Author), Felix Weihsengruber (Author), Klemens Rappersberger (Author), Wolfgang Bauer (Author), Ingrid Simonitsch-Klupp (Author), Markus Raderer (Author), Julia Valencak (Author)
• Format: Book
• Published: Medical Journals Sweden, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Systemic monotherapy with rituximab is a well-known treatment approach for primary cutaneous follicle centre lymphoma and primary cutaneous marginal zone lymphoma. Both have excellent prognosis despite high relapse rates. To investigate the long-term effectiveness and clinical outcome of intravenous...